web analytics

The Exciting Story of Univec, Inc. (OTCMKTS: UNVC)

1

UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher.

The Company is making moves in the cannabis space which is booming! according to a recent report published by Forbes, Brightfield Group projects that the global cannabis market was worth $7.7 billion in the end of 2017, and is projected to reach $31.4 billion by 2021 with the US currently dominating the market. According to a new report from Deloitte the legal recreational cannabis industry could be worth $7 billion annually in Canada by next year.

UNIVEC, Inc. (OTCMKTS: UNVC) is a Specialty Pharmaceutical Company with a couple of exciting projects in the pipeline. The Company is led by mover and shaker; Dr. Dalton,e an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.

Last year Univec entered into a partnership with Agrimed to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream.

Agrimed is a Delaware Company developing, producing and selling products derived from cannabis. Agrimed owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis. Agrimed has teamed up with Former Pittsburgh Steelers great Jack Ham, a native of Johnstown, to promote the use of medical marijuana in Pennsylvania

Dr. David Dalton, Univec’s CEO said “Combining Univec’s medical and pharmaceutical expertise with AGRiMED Industries’ innovative approach to the cannabis marketplace and commitment to its patient focused services makes for a very powerful partnership to expand the treatment options available to the medical community.”

To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On October 20, Agrimed announced the election of Dr. David Dalton to their Board of Directors, effective immediately. In addition to over 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, a chain of retail drug stores, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies: Mednet, ManagedcareRx, Sivault Systems. Dr. Dalton is presently Chairman, President, CEO of Wellness Teladoc, Pharmacy Services Inc, Health Resources Inc and Univec Inc (UNVC). Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom.

Univec CEO Dr. David Dalton recently posted on linkedin “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” CBD stocks are on fire right now since reported surfaced that Coca-Cola is monitoring the nascent industry and is interested in drinks infused with CBD. With a rising number of various CBD products available in mainstream markets, consumers are spending more on CBD products than ever before. The Brightfield Group estimates the space will top $22 billion within the next 4 years, making it one of the more enticing spaces from an opportunity standpoint.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec. CEO Dr. Dalton has been very active getting elected to the board of Agrimed several days ago. He has also been busy on Linkedin recent posting “Univec Transdermal CBD Patch will have patient assistance programs including no cost.” We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in UNVC either long or short and we have not been compensated for this article.

Share.

1 Comment

  1. JV with $MRK in the works at $UNVC. Dr Dalton has many years working experience with Merck CEO Ken Frazier. They are working on a transdermal CBD oil patch with Merck Subsidiary MilliporeSigma. Patch is ready and Univec has the oil. Great spinoff for Merck to enter CBD market and amazing potential growth factor for Univec. It’s a win – win situation!

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.